{"id":"https://openalex.org/W2900380873","doi":"https://doi.org/10.1093/neuonc/noy148.234","title":"CMET-22. INTRATHECAL (IT) TRAZTUZUMAB (T) FOR THE TREATMENT OF LEPTOMENINGEAL METASTASES (LM) IN PATIENTS (PTS) WITH HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-POSITIVE (HER2+) CANCER: A MULTICENTER PHASE 1/2 STUDY","display_name":"CMET-22. INTRATHECAL (IT) TRAZTUZUMAB (T) FOR THE TREATMENT OF LEPTOMENINGEAL METASTASES (LM) IN PATIENTS (PTS) WITH HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-POSITIVE (HER2+) CANCER: A MULTICENTER PHASE 1/2 STUDY","publication_year":2018,"publication_date":"2018-11-01","ids":{"openalex":"https://openalex.org/W2900380873","doi":"https://doi.org/10.1093/neuonc/noy148.234","mag":"2900380873"},"language":"en","primary_location":{"id":"doi:10.1093/neuonc/noy148.234","doi":"https://doi.org/10.1093/neuonc/noy148.234","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noy148.234","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/20/suppl_6/vi58/26280957/noy148.234.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/neuro-oncology/article-pdf/20/suppl_6/vi58/26280957/noy148.234.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091750059","display_name":"Priya Kumthekar","orcid":"https://orcid.org/0000-0001-5923-0677","observed_orcids":["https://orcid.org/0000-0001-5923-0677"]},"institutions":[{"id":"https://openalex.org/I4210147348","display_name":"Northwestern Medicine","ror":"https://ror.org/04fzwnh64","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210147348"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Priya Kumthekar","raw_affiliation_strings":["Northwestern Medicine, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northwestern Medicine, Chicago, IL, USA","institution_ids":["https://openalex.org/I4210147348"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085028425","display_name":"William John Gradishar","orcid":"https://orcid.org/0000-0002-2772-3140","observed_orcids":["https://orcid.org/0000-0002-2772-3140"]},"institutions":[{"id":"https://openalex.org/I4210147348","display_name":"Northwestern Medicine","ror":"https://ror.org/04fzwnh64","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210147348"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William Gradishar","raw_affiliation_strings":["Northwestern Medicine, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northwestern Medicine, Chicago, IL, USA","institution_ids":["https://openalex.org/I4210147348"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022319770","display_name":"NU Lin","orcid":"https://orcid.org/0000-0003-2263-5413","observed_orcids":["https://orcid.org/0000-0003-2263-5413"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nancy Lin","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA, USA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009476786","display_name":"Elena I. Pentsova","orcid":"https://orcid.org/0000-0001-5854-0251","observed_orcids":["https://orcid.org/0000-0001-5854-0251"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elena Pentsova","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY, USA","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110346854","display_name":"Morris D. Groves","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Morris Groves","raw_affiliation_strings":["Texas Oncology Austin Brain Tumor Center, Austin, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Texas Oncology Austin Brain Tumor Center, Austin, TX, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021790010","display_name":"Suriya A. Jeyapalan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1290900354","display_name":"Tufts Medical Center","ror":"https://ror.org/002hsbm82","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1290900354"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Suriya Jeyapalan","raw_affiliation_strings":["Tufts Medical Center, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tufts Medical Center, Boston, MA, USA","institution_ids":["https://openalex.org/I1290900354"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000761973","display_name":"Michelle Melisko","orcid":"https://orcid.org/0000-0002-8729-4667","observed_orcids":["https://orcid.org/0000-0002-8729-4667"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michelle Melisko","raw_affiliation_strings":["University of California San Francisco, San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Francisco, San Francisco, CA, USA","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041824343","display_name":"Sean Aaron Grimm","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sean Grimm","raw_affiliation_strings":["Northwestern University, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northwestern University, Chicago, IL, USA","institution_ids":["https://openalex.org/I111979921"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057541817","display_name":"Andrew B. Lassman","orcid":"https://orcid.org/0000-0001-7386-9928","observed_orcids":["https://orcid.org/0000-0001-7386-9928"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]},{"id":"https://openalex.org/I4390039230","display_name":"Herbert Irving Comprehensive Cancer Center","ror":"https://ror.org/051kc1939","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039230"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew B. Lassman","raw_affiliation_strings":["Department of Neurology and Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology and Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA","institution_ids":["https://openalex.org/I2799503643","https://openalex.org/I4390039230"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5029952866","display_name":"Jeffrey J. Raizer","orcid":"https://orcid.org/0009-0003-8469-2509","observed_orcids":["https://orcid.org/0009-0003-8469-2509"]},"institutions":[{"id":"https://openalex.org/I111979921","display_name":"Northwestern University","ror":"https://ror.org/000e0be47","country_code":"US","type":"education","lineage":["https://openalex.org/I111979921"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey Raizer","raw_affiliation_strings":["Northwestern University, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northwestern University, Chicago, IL, USA","institution_ids":["https://openalex.org/I111979921"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5132,"currency":"USD","value_usd":5132},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":10,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"20","issue":"suppl_6","first_page":"vi58","last_page":"vi58"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11600","display_name":"Brain Metastases and Treatment","score":0.9520999789237976,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11600","display_name":"Brain Metastases and Treatment","score":0.9520999789237976,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.03310000151395798,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.8899999856948853},{"id":"https://openalex.org/keywords/intrathecal-administration","display_name":"intrathecal administration","score":0.9070000052452087},{"id":"https://openalex.org/keywords/leptomeningeal-metastasis","display_name":"leptomeningeal metastasis","score":0.9079999923706055},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9750000238418579},{"id":"https://openalex.org/keywords/ommaya-reservoir","display_name":"Ommaya reservoir","score":0.7749999761581421},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.765999972820282},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.8190000057220459},{"id":"https://openalex.org/keywords/intraventricular-chemotherapy","display_name":"intraventricular chemotherapy","score":0.6980000138282776},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6520000100135803},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6660000085830688},{"id":"https://openalex.org/keywords/response-rate","display_name":"response rate","score":0.6050000190734863},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.5809999704360962}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.849189043045044},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.5984902381896973},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5928024053573608},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.5628256797790527},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5418537259101868},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5225607752799988},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.41782766580581665},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.41065773367881775},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3986853361129761},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.36071687936782837},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.36063745617866516},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3538290858268738},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2719937860965729}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/neuonc/noy148.234","doi":"https://doi.org/10.1093/neuonc/noy148.234","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noy148.234","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/20/suppl_6/vi58/26280957/noy148.234.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6216912","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6216912","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro Oncol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/neuonc/noy148.234","doi":"https://doi.org/10.1093/neuonc/noy148.234","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noy148.234","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/20/suppl_6/vi58/26280957/noy148.234.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2900380873.pdf","grobid_xml":"https://content.openalex.org/works/W2900380873.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2968082104","https://openalex.org/W7129427299","https://openalex.org/W2805638727","https://openalex.org/W4388589474","https://openalex.org/W2331851498","https://openalex.org/W2893728300","https://openalex.org/W2796338303","https://openalex.org/W1513952874","https://openalex.org/W4401305071","https://openalex.org/W4367317724"],"abstract_inverted_index":{"Pts":[0,76,120],"with":[1,61,106,142,155,171],"HER2+":[2,297],"breast":[3,192],"cancer":[4],"have":[5],"frequent":[6],"LM.":[7,298],"No":[8],"current":[9],"FDA":[10],"approvals":[11],"exist.":[12],"A":[13],"multicenter":[14],"phase":[15,34,158,182,188,198,217,237],"I/II":[16],"trial":[17],"assessing":[18],"safety":[19],"and":[20,64,114,230,248],"efficacy":[21],"of":[22,145,264,275],"IT":[23,78,166,256,294],"T":[24,79,167,257,295],"in":[25,33,109,112,157,187,196,296],"LM":[26,134],"pts":[27,152,185,195,220,242,276],"was":[28,36,103,131,139,163,168,178,206,212,243,251,258,270],"conducted.":[29],"The":[30,160],"primary":[31],"endpoint":[32,267],"2":[35,189,194,207,238],"response":[37,41,56],"rate":[38],"(RR).":[39],"Complete":[40],"(CR)":[42],"required":[43,58],"cytologic":[44],"CR":[45,49],"(CCR)":[46],"+":[47,51,69,72],"radiographic":[48],"(RCR)":[50],"stable":[52,70,227],"clinical":[53,65,74,278],"function.":[54],"Partial":[55],"(PR)":[57],"either":[59],"CCR":[60],"stable/improved":[62],"imaging":[63],"function":[66],"or":[67,281],"RCR":[68],"cytology":[71],"stable/improving":[73],"functioning.":[75],"received":[77],"via":[80],"an":[81],"intraventricular":[82],"Ommaya":[83],"reservoir.":[84],"Phase":[85],"I":[86],"dosing":[87],"started":[88],"at":[89,133],"10":[90],"mg,":[91],"then":[92],"increasing":[93],"by":[94],"20":[95],"mg":[96,180],"up":[97,211,260],"to":[98,123,261,292],"80mg.":[99,265],"Each":[100],"cycle":[101],"(C)":[102],"4":[104],"weeks":[105,117],"2x/week":[107],"treatment":[108,147],"C1,":[110],"weekly":[111],"C2,":[113],"every":[115],"two":[116],"after":[118],"C2.":[119],"were":[121,153],"allowed":[122],"continue":[124],"on":[125],"hormonal":[126],"agents":[127],"if":[128],"systemic":[129],"disease":[130,228],"controlled":[132],"development.":[135],"Concurrent":[136],"radiation":[137],"therapy":[138],"not":[140,271],"allowed,":[141],"the":[143,197],"exception":[144],"localized":[146],"for":[148,181],"pain":[149],"control.":[150],"34":[151],"enrolled":[154],"26":[156],"2.":[159,183],"median":[161,240,249,283],"age":[162],"51":[164],"(25\u201369).":[165],"well":[169],"tolerated":[170,259],"no":[172],"DLTs":[173],"seen":[174],"throughout;":[175],"determined":[176],"MTD":[177],"80":[179],"All":[184],"treated":[186],"had":[190,200,222,226,233],"Her2+":[191],"cancer,":[193],"1":[199],"non-breast":[201],"histologies.":[202],"Median":[203,209],"cycles":[204],"completed":[205],"(1\u201322).":[208],"follow":[210],"9.1":[213],"months":[214,245,253],"(0.4\u201328.9).":[215],"In":[216],"2,":[218],"5":[219],"(19.2%)":[221],"PR,":[223],"13":[224],"(50%)":[225],"(SD)":[229],"8":[231],"(30.8%)":[232],"progressive":[234],"disease.":[235],"For":[236],"pts,":[239],"PFS":[241],"2.4":[244],"(CI":[246,254],"1.0\u20135.5)":[247],"OS":[250,284],"12.1":[252],"4.3\u201319.6).":[255],"a":[262],"dose":[263],"Primary":[266],"(25%":[268],"RR)":[269],"met,":[272],"however":[273],"69%":[274],"showed":[277],"benefit":[279],"(SD":[280],"better);":[282],"exceeded":[285],"historical":[286],"controls.":[287],"Future":[288],"studies":[289],"are":[290],"warranted":[291],"evaluate":[293]},"counts_by_year":[{"year":2022,"cited_by_count":4},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-11-16T00:00:00"}